-
Signature
-
Michael J. Farrell, Chief Executive Officer
-
Issuer symbol
-
RMD
-
Transactions as of
-
07 May 2024
-
Net transactions value
-
-$1,931,054
-
Form type
-
4
-
Filing time
-
09 May 2024, 11:58:06 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$99,936 |
+1,176 |
+0.27% |
$84.98 |
441,928 |
07 May 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Options Exercise |
$1,147,825 |
+13,507 |
+3.1% |
$84.98 |
455,435 |
07 May 2024 |
Direct |
F1 |
| transaction |
RMD |
ResMed Common Stock |
Sale |
$3,178,815 |
-14,683 |
-3.2% |
$216.50 |
440,752 |
07 May 2024 |
Direct |
F1, F2 |
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
0 |
07 May 2024 |
Lisette and Michael Farrell Foundation |
|
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
4,090 |
07 May 2024 |
Lisette and Michael Farrell Family Trust |
|
| holding |
RMD |
ResMed Common Stock |
|
|
|
|
|
0 |
07 May 2024 |
Lisette & Michael Farrell Family Foundation |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-1,176 |
-1.1% |
$0.000000 |
101,605 |
07 May 2024 |
ResMed Common Stock |
1,176 |
$84.98 |
Direct |
F3 |
| transaction |
RMD |
ResMed Common Stock Options |
Options Exercise |
$0 |
-13,507 |
-13% |
$0.000000 |
88,098 |
07 May 2024 |
ResMed Common Stock |
13,507 |
$84.98 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: